{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T07:41:46Z","timestamp":1765438906492,"version":"3.40.5"},"reference-count":48,"publisher":"Bentham Science Publishers Ltd.","issue":"2","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CRR"],"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>Ankylosing spondylitis (AS) is a chronic inflammatory rheumatic disease that predominantly\naffects young males. AS is a condition in which the spine and sacroiliac joints become inflamed.\nMore specifically, most AS patients experience spine malformations over time, resulting\nin functional incapability. The etiopathogenesis of AS is a complex combination of genetic predisposition\nand environmental factors. Extensive studies on AS have revealed the central role of genetics\nand immune reactions in its etiology. However, an utmost agreement has yet to be created.\nThe available evidence suggests that both autoinflammation and T-cell-mediated autoimmune processes\nhave significant roles in the disease process of AS. So far, B cells have obtained moderately\nlittle attention in AS pathogenesis, primarily because of the absence of disease-defining autoantibodies.\nHowever, against general dogma, evidence is mounting showing B cell involvement.\nDisruptions depict this in circulating B cell populations, the increased expression of immunoglobulin\n(Ig)G, IgA, and IgM, and B cell infiltration within the axial skeleton of AS patients.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>:<\/jats:title>\n<jats:p>Meanwhile, compared to many other inflammatory autoimmune disorders, AS has no disease-specific\nautoantibodies that help disease diagnosis. This study has provided an overview of the B lymphocytes\nand antibodies' role in AS pathogenesis. It also introduces autoantibodies that can be the\nprognosis and diagnosis biomarkers of AS.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0115733971243468231012044909","type":"journal-article","created":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T10:07:57Z","timestamp":1698055677000},"page":"157-164","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Potential Roles for B cells and Autoantibodies in Ankylosing Spondylitis"],"prefix":"10.2174","volume":"20","author":[{"given":"Samaneh","family":"Soltani","sequence":"first","affiliation":[{"name":"Rheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmadreza","family":"Jamshidi","sequence":"additional","affiliation":[{"name":"Rheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahdi","family":"Mahmoudi","sequence":"additional","affiliation":[{"name":"Rheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran"},{"name":"Research Center for Chronic\nInflammatory Diseases, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4324-2697","authenticated-orcid":true,"given":"Elham","family":"Farhadi","sequence":"additional","affiliation":[{"name":"Rheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran"},{"name":"Research Center for Chronic\nInflammatory Diseases, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41413-019-0057-8","volume":"7","author":"Zhu W.","year":"2019","unstructured":"Zhu W.; He X.; Cheng K.; Zhang L.; Chen D.; Wang X.; Qiu G.; Cao X.; Weng X.; Ankylosing spondylitis: Etiology, pathogenesis, and treatments. Bone Res  2019,7(1),22","journal-title":"Bone Res"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.ejr.2020.08.003","volume":"42","author":"Malakar A.","year":"2020","unstructured":"Malakar A.; Kakati S.; Barman B.; Dutta A.; Clinical presentation and subtypes of spondyloarthritis patients in North East India. Egypt Rheumatol  2020,42(4),271-274","journal-title":"Egypt Rheumatol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1111\/1756-185X.12779","volume":"18","author":"Danve A.","year":"2015","unstructured":"Danve A.; O\u2019Dell J.; The ongoing quest for biomarkers in ankylosing spondylitis. Int J Rheum Dis  2015,18(8),826-834","journal-title":"Int J Rheum Dis"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/S0140-6736(07)60635-7","volume":"369","author":"Braun J.","year":"2007","unstructured":"Braun J.; Sieper J.; Ankylosing spondylitis. Lancet  2007,369(9570),1379-1390","journal-title":"Lancet"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"8521","DOI":"10.2147\/IJN.S216199","volume":"14","author":"Xi Y.","year":"2019","unstructured":"Xi Y.; Jiang T.; Chaurasiya B.; Zhou Y.; Yu J.; Wen J.; Shen Y.; Ye X.; Webster T.J.; Advances in nanomedicine for the treatment of ankylosing spondylitis. Int J Nanomed  2019,14,8521-8542","journal-title":"Int J Nanomed"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1136\/ard.35.2.155","volume":"35","author":"Eghtedari A.A.","year":"1976","unstructured":"Eghtedari A.A.; Davis P.; Bacon P.A.; Immunological reactivity in ankylosing spondylitis. Circulating immunoblasts, autoantibodies, and immunoglobulins. Ann Rheum Dis  1976,35(2),155-157","journal-title":"Ann Rheum Dis"},{"key":"ref=7","first-page":"186","volume":"16","author":"Burgos-Vargas R.","year":"1989","unstructured":"Burgos-Vargas R.; Naranjo A.; Castillo J.; Katona G.; Ankylosing spondylitis in the Mexican mestizo: Patterns of disease according to age at onset. J Rheumatol  1989,16(2),186-191","journal-title":"J Rheumatol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"M9.00384","DOI":"10.1074\/mcp.M9.00384","volume":"11","author":"Wright C.","year":"2012","unstructured":"Wright C.; Sibani S.; Trudgian D.; Fischer R.; Kessler B.; LaBaer J.; Bowness P.; Detection of multiple autoantibodies in patients with ankylosing spondylitis using nucleic acid programmable protein arrays. Mol Cell Proteomics  2012,11(2),M9.00384","journal-title":"Mol Cell Proteomics"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.autrev.2016.06.001","volume":"15","author":"Quaden D.H.F.","year":"2016","unstructured":"Quaden D.H.F.; De Winter L.M.; Somers V.; Detection of novel diagnostic antibodies in ankylosing spondylitis: An overview. Autoimmun Rev  2016,15(8),820-832","journal-title":"Autoimmun Rev"},{"key":"ref=10","first-page":"1784","volume":"122","author":"Lin Q.","year":"2009","unstructured":"Lin Q.; Gu J.R.; Li T.W.; Zhang F.C.; Lin Z.M.; Liao Z.T.; Wei Q.J.; Cao S.Y.; Li L.; Value of the peripheral blood B-cells subsets in patients with ankylosing spondylitis. Chin Med J  2009,122(15),1784-1789","journal-title":"Chin Med J"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1002\/art.22060","volume":"54","author":"Appel H.","year":"2006","unstructured":"Appel H.; Kuhne M.; Spiekermann S.; Ebhardt H.; Grozdanovic Z.; K\u00f6hler D.; Dreimann M.; Hempfing A.; Rudwaleit M.; Stein H.; Metz-Stavenhagen P.; Sieper J.; Loddenkemper C.; Immunohistologic analysis of zygapophyseal joints in patients with ankylosing spondylitis. Arthritis Rheum  2006,54(9),2845-2851","journal-title":"Arthritis Rheum"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.lfs.2013.09.003","volume":"93","author":"Niu X.Y.","year":"2013","unstructured":"Niu X.Y.; Zhang H.Y.; Liu Y.J.; Zhao D.; Shan Y.X.; Jiang Y.F.; Peripheral B-cell activation and exhaustion markers in patients with ankylosing spondylitis. Life Sci  2013,93(18-19),687-692","journal-title":"Life Sci"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.3389\/fimmu.2019.02458","volume":"10","author":"Sanz I.","year":"2019","unstructured":"Sanz I.; Wei C.; Jenks S.A.; Cashman K.S.; Tipton C.; Woodruff M.C.; Hom J.; Lee F.E.H.; Challenges and opportunities for consistent classification of human B cell and plasma cell populations. Front Immunol  2019,10,2458","journal-title":"Front Immunol"},{"key":"ref=14","first-page":"2527","volume":"22","author":"Ge L.","year":"2018","unstructured":"Ge L.; Wang J.; Zhu B.Q.; Zhang Z.S.; Effect of abnormal activated B cells in patients with ankylosing spondylitis and its molecular mechanism. Eur Rev Med Pharmacol Sci  2018,22(9),2527-2533","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1007\/s10067-022-06137-8","volume":"41","author":"Zhang Y.","year":"2022","unstructured":"Zhang Y.; Wei S.; Wu Q.; Shen X.; Dai W.; Zhang Z.; Chen M.; Huang H.; Ma L.; Interleukin-35 promotes Breg expansion and interleukin-10 production in CD19 B cells in patients with ankylosing spondylitis. Clin Rheumatol  2022,41(8),2403-2416","journal-title":"Clin Rheumatol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1136\/ard.41.6.579","volume":"41","author":"Revell P.A.","year":"1982","unstructured":"Revell P.A.; Mayston V.; Histopathology of the synovial membrane of peripheral joints in ankylosing spondylitis. Ann Rheum Dis  1982,41(6),579-586","journal-title":"Ann Rheum Dis"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"250","DOI":"10.3892\/etm.2014.2046","volume":"9","author":"Wang C.","year":"2015","unstructured":"Wang C.; Liao Q.; Hu Y.; Zhong D.; T lymphocyte subset imbalances in patients contribute to ankylosing spondylitis. Exp Ther Med  2015,9(1),250-256","journal-title":"Exp Ther Med"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1186\/ar3918","volume":"14","author":"Giltiay N.V.","year":"2012","unstructured":"Giltiay N.V.; Chappell C.P.; Clark E.A.; B-cell selection and the development of autoantibodies. Arthritis Res Ther  2012,14(Suppl 4),S1","journal-title":"Arthritis Res Ther"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1093\/rheumatology\/kel072","volume":"45","author":"Kim H.R.","year":"2006","unstructured":"Kim H.R.; Kim H-Y.; Lee S-H.; Elevated serum levels of soluble receptor activator of nuclear factors- B ligand (sRANKL) and reduced bone mineral density in patients with ankylosing spondylitis (AS). Rheumatology  2006,45(10),1197-1200","journal-title":"Rheumatology"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"13325","DOI":"10.3390\/ijms222413325","volume":"22","author":"Wilbrink R.","year":"2021","unstructured":"Wilbrink R.; Spoorenberg A.; Verstappen G.M.P.J.; Kroese F.G.M.; B cell involvement in the pathogenesis of ankylosing spondylitis. Int J Mol Sci  2021,22(24),13325","journal-title":"Int J Mol Sci"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1080\/08820139.2019.1567531","volume":"48","author":"Chen M.","year":"2019","unstructured":"Chen M.; Hu X.; Wu M.; Yang J.; Han R.; Ma Y.; Zhang X.; Yuan Y.; Liu R.; Wang M.; Jiang G.; Deng J.; Xu S.; Xu J.; Shuai Z.; Pan F.; Serum levels of OPG, RANKL, and RANKL\/OPG ratio in patients with ankylosing spondylitis: A systematic review and meta-analysis. Immunol Invest  2019,48(5),490-504","journal-title":"Immunol Invest"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s00223-017-0291-2","volume":"101","author":"Hauser B.","year":"2017","unstructured":"Hauser B.; Zhao S.; Visconti M.R.; Riches P.L.; Fraser W.D.; Piec I.; Goodson N.J.; Ralston S.H.; Autoantibodies to osteoprotegerin are associated with low hip bone mineral density and history of fractures in axial spondyloarthritis: A cross-sectional observational study. Calcif Tissue Int  2017,101(4),375-383","journal-title":"Calcif Tissue Int"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"e0178520","DOI":"10.1371\/journal.pone.0178520","volume":"12","author":"Zainabadi K.","year":"2017","unstructured":"Zainabadi K.; Liu C.J.; Guarente L.; SIRT1 is a positive regulator of the master osteoblast transcription factor, RUNX2. PLoS One  2017,12(5),e0178520","journal-title":"PLoS One"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"119041","DOI":"10.1016\/j.lfs.2021.119041","volume":"269","author":"Chen Y.","year":"2021","unstructured":"Chen Y.; Zhou F.; Liu H.; Li J.; Che H.; Shen J.; Luo E.; SIRT1, a promising regulator of bone homeostasis. Life Sci  2021,269,119041","journal-title":"Life Sci"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12865-018-0280-x","volume":"19","author":"Hu Q.","year":"2018","unstructured":"Hu Q.; Sun Y.; Li Y.; Shi H.; Teng J.; Liu H.; Cheng X.; Ye J.; Su Y.; Yin Y.; Liu M.; Wang J.; Yang C.; Anti-SIRT1 autoantibody is elevated in ankylosing spondylitis: A potential disease biomarker. BMC Immunol  2018,19(1),38","journal-title":"BMC Immunol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1136\/annrheumdis-2013-203630","volume":"73","author":"Tsui F.W.L.","year":"2014","unstructured":"Tsui F.W.L.; Tsui H.W.; Las Heras F.; Pritzker K.P.H.; Inman R.D.; Serum levels of novel noggin and sclerostin-immune complexes are elevated in ankylosing spondylitis. Ann Rheum Dis  2014,73(10),1873-1879","journal-title":"Ann Rheum Dis"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.1002\/art.24888","volume":"60","author":"Appel H.","year":"2009","unstructured":"Appel H.; Ruiz-Heiland G.; Listing J.; Zwerina J.; Herrmann M.; Mueller R.; Haibel H.; Baraliakos X.; Hempfing A.; Rudwaleit M.; Sieper J.; Schett G.; Altered skeletal expression of sclerostin and its link to radiographic progression in ankylosing spondylitis. Arthritis Rheum  2009,60(11),3257-3262","journal-title":"Arthritis Rheum"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"630","DOI":"10.3899\/jrheum.170833","volume":"45","author":"Luchetti M.M.","year":"2018","unstructured":"Luchetti M.M.; Ciccia F.; Avellini C.; Benfaremo D.; Guggino G.; Farinelli A.; Ciferri M.; Rossini M.; Svegliati S.; Spadoni T.; Bolognini L.; Fava G.; Mosca P.; Gesuita R.; Skrami E.; Triolo G.; Gabrielli A.; Sclerostin and antisclerostin antibody serum levels predict the presence of axial spondyloarthritis in patients with inflammatory bowel disease. J Rheumatol  2018,45(5),630-637","journal-title":"J Rheumatol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1002\/art.38763","volume":"66","author":"Kim Y.G.","year":"2014","unstructured":"Kim Y.G.; Sohn D.H.; Zhao X.; Sokolove J.; Lindstrom T.M.; Yoo B.; Lee C.K.; Reveille J.D.; Taurog J.D.; Robinson W.H.; Role of protein phosphatase magnesium-dependent 1A and anti-protein phosphatase magnesium-dependent 1A autoantibodies in ankylosing spondylitis. Arthritis Rheumatol  2014,66(10),2793-2803","journal-title":"Arthritis Rheumatol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1002\/art.41180","volume":"72","author":"Kwon O.C.","year":"2020","unstructured":"Kwon O.C.; Choi B.; Lee E.J.; Park J.E.; Lee E.J.; Kim E.Y.; Kim S.M.; Shin M.K.; Kim T.H.; Hong S.; Lee C.K.; Yoo B.; Robinson W.H.; Kim Y.G.; Chang E.J.; Negative regulation of osteoclast commitment by intracellular protein phosphatase magnesium-dependent 1A. Arthritis Rheumatol  2020,72(5),750-760","journal-title":"Arthritis Rheumatol"},{"key":"ref=31","first-page":"295","volume":"15","author":"Tani Y.","year":"1997","unstructured":"Tani Y.; Sato H.; Hukuda S.; Autoantibodies to collagens in Japanese patients with ankylosing spondylitis. Clin Exp Rheumatol  1997,15(3),295-297","journal-title":"Clin Exp Rheumatol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"5318","DOI":"10.1038\/s41598-018-23532-x","volume":"8","author":"Elango J.","year":"2018","unstructured":"Elango J.; Sanchez C.; de Val J.E.M.S.; Henrotin Y.; Wang S.; Motaung K.S.C.M.; Guo R.; Wang C.; Robinson J.; Regenstein J.M.; Bao B.; Wu W.; Cross-talk between primary osteocytes and bone marrow macrophages for osteoclastogenesis upon collagen treatment. Sci Rep  2018,8(1),5318","journal-title":"Sci Rep"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"2680","DOI":"10.1016\/j.biomaterials.2013.12.005","volume":"35","author":"Chiu L.H.","year":"2014","unstructured":"Chiu L.H.; Lai W.F.T.; Chang S.F.; Wong C.C.; Fan C.Y.; Fang C.L.; Tsai Y.H.; The effect of type II collagen on MSC osteogenic differentiation and bone defect repair. Biomaterials  2014,35(9),2680-2691","journal-title":"Biomaterials"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/rheumatology\/40.1.15","volume":"40","author":"Tiwana H.","year":"2001","unstructured":"Tiwana H.; Natt R.S.; Benitez-Brito R.; Shah S.; Wilson C.; Bridger S.; Harbord M.; Sarner M.; Ebringer A.; Correlation between the immune responses to collagens type I, III, IV and V and Klebsiella pneumoniae in patients with Crohn\u2019s disease and ankylosing spondylitis. Rheumatology  2001,40(1),15-23","journal-title":"Rheumatology"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1046\/j.1365-2249.1999.01008.x","volume":"117","author":"Locht H.","year":"2001","unstructured":"Locht H.; Skogh T.; Kihlstr\u00f6m E.; Anti-lactoferrin antibodies and other types of anti-neutrophil cytoplasmic antibodies (ANCA) in reactive arthritis and ankylosing spondylitis. Clin Exp Immunol  2001,117(3),568-573","journal-title":"Clin Exp Immunol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.3899\/jrheum.100269","volume":"37","author":"de Vries M.","year":"2010","unstructured":"de Vries M.; van der Horst-Bruinsma I.; van Hoogstraten I.; van Bodegraven A.; von Blomberg M.; Ratnawati H.; Dijkmans B.; pANCA, ASCA, and OmpC antibodies in patients with ankylosing spondylitis without inflammatory bowel disease. J Rheumatol  2010,37(11),2340-2344","journal-title":"J Rheumatol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.humimm.2018.07.004","volume":"80","author":"Dixon A.M.","year":"2019","unstructured":"Dixon A.M.; Roy S.; Role of membrane environment and membrane-spanning protein regions in assembly and function of the Class II Major Histocompatibility complex. Hum Immunol  2019,80(1),5-14","journal-title":"Hum Immunol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s00251-018-1090-2","volume":"71","author":"Dijkstra J.M.","year":"2019","unstructured":"Dijkstra J.M.; Yamaguchi T.; Ancient features of the MHC class II presentation pathway, and a model for the possible origin of MHC molecules. Immunogenetics  2019,71(3),233-249","journal-title":"Immunogenetics"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/j.bbamcr.2016.03.026","volume":"1863","author":"Schr\u00f6der B.","year":"2016","unstructured":"Schr\u00f6der B.; The multifaceted roles of the invariant chain CD74 \u2014 More than just a chaperone. Biochim Biophys Acta Mol Cell Res  2016,1863(6),1269-1281","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1136\/annrheumdis-2012-202177","volume":"73","author":"Baraliakos X.","year":"2014","unstructured":"Baraliakos X.; Baerlecken N.; Witte T.; Heldmann F.; Braun J.; High prevalence of anti-CD74 antibodies specific for the HLA class II-associated invariant chain peptide (CLIP) in patients with axial spondyloarthritis: Table 1. Ann Rheum Dis  2014,73(6),1079-1082","journal-title":"Ann Rheum Dis"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"574","DOI":"10.3389\/fimmu.2019.00574","volume":"10","author":"Ziade N.R.","year":"2019","unstructured":"Ziade N.R.; Mallak I.; Merheb G.; Ghorra P.; Baerlecken N.; Witte T.; Baraliakos X.; Added value of anti-CD74 autoantibodies in axial spondyloarthritis in a population with low HLA-B27 prevalence. Front Immunol  2019,10,574","journal-title":"Front Immunol"},{"key":"ref=42","author":"Xu S.","year":"2021","unstructured":"Xu S.; Zhang X.; Chen Y.; Ma Y.; Deng J.; Gao X.; Anti-CD74 antibodies in spondyloarthritis: A systematic review and meta-analysis. Seminars in Arthritis and Rheumatism  2021","journal-title":"Seminars in Arthritis and Rheumatism"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1002\/eji.201948502","volume":"50","author":"van Kempen T.S.","year":"2020","unstructured":"van Kempen T.S.; Leijten E.F.A.; Lindenbergh M.F.S.; Nordkamp M.O.; Driessen C.; Lebbink R.J.; Baerlecken N.; Witte T.; Radstake T.R.D.J.; Boes M.; Impaired proteolysis by SPPL2a causes CD74 fragment accumulation that can be recognized by anti-CD74 autoantibodies in human ankylosing spondylitis. Eur J Immunol  2020,50(8),1209-1219","journal-title":"Eur J Immunol"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1136\/ard.56.7.421","volume":"56","author":"M\u00e4ki-Ikola O.","year":"1997","unstructured":"M\u00e4ki-Ikola O.; H\u00e4llgren R.; Kanerud L.; Feltelius N.; Knutsson L.; Granfors K.; Enhanced jejunal production of antibodies to Klebsiella and other Enterobacteria in patients with ankylosing spondylitis and rheumatoid arthritis. Ann Rheum Dis  1997,56(7),421-425","journal-title":"Ann Rheum Dis"},{"key":"ref=45","first-page":"299","volume":"12","author":"Smith M.D.","year":"1985","unstructured":"Smith M.D.; Gibson R.A.; Brooks P.M.; Abnormal bowel permeability in ankylosing spondylitis and rheumatoid arthritis. J Rheumatol  1985,12(2),299-305","journal-title":"J Rheumatol"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"R166","DOI":"10.1186\/ar4350","volume":"15","author":"Wallis D.","year":"2013","unstructured":"Wallis D.; Asaduzzaman A.; Weisman M.; Haroon N.; Anton A.; McGovern D.; Targan S.; Inman R.; Elevated serum anti-flagellin antibodies implicate subclinical bowel inflammation in ankylosing spondylitis: An observational study. Arthritis Res Ther  2013,15(5),R166","journal-title":"Arthritis Res Ther"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1093\/rheumatology\/kei109","volume":"45","author":"Duftner C.","year":"2006","unstructured":"Duftner C.; Dejaco C.; Klauser A.; Falkenbach A.; Lakomek H.J.; Schirmer M.; High positive predictive value of specific antibodies cross-reacting with a 28-kDa Drosophila antigen for diagnosis of ankylosing spondylitis. Rheumatology  2006,45(1),38-42","journal-title":"Rheumatology"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1093\/rheumatology\/36.4.491","volume":"36","author":"Tani Y.","year":"1997","unstructured":"Tani Y.; Sato H.; Tanaka N.; Hukuda S.; Antibodies against bacterial lipopolysaccharides in Japanese patients with ankylosing spondylitis. Rheumatology  1997,36(4),491-493","journal-title":"Rheumatology"}],"container-title":["Current Rheumatology Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115733971243468231012044909","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/222489\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115733971243468231012044909","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T05:41:03Z","timestamp":1711345263000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/222489\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0115733971243468231012044909","relation":{},"ISSN":["1573-3971"],"issn-type":[{"type":"print","value":"1573-3971"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-12-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-26","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-01-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}